Journal of Asthma
Volume 60, 2023 - Issue 10
Research Articles
Evaluation of the clinical features and laboratory data of patients with severe asthma classified as super-responder or non super-responder to omalizumab treatment: a single-center real-life study
Mehmet Erdem CakmakDepartment of Allergy and Clinical Immunology, Istanbul Başakşehir Çam and Sakura City Hospital, Istanbul, TurkeyCorrespondence[email protected]
https://orcid.org/0000-0001-7899-3004View further author information
, M.Dhttps://orcid.org/0000-0001-7899-3004View further author information, Nida ÖztopDepartment of Allergy and Clinical Immunology, Istanbul Başakşehir Çam and Sakura City Hospital, Istanbul, Turkeyhttps://orcid.org/0000-0003-2607-3833View further author information
, M.D.https://orcid.org/0000-0003-2607-3833View further author information, Osman Ozan YeğitDepartment of Allergy and Clinical Immunology, Istanbul Başakşehir Çam and Sakura City Hospital, Istanbul, Turkeyhttps://orcid.org/0000-0003-4256-6048View further author information
, M.D.https://orcid.org/0000-0003-4256-6048View further author information & Özlem ÖzdedeoğluDepartment of Allergy and Clinical Immunology, Istanbul Başakşehir Çam and Sakura City Hospital, Istanbul, Turkeyhttps://orcid.org/0000-0001-8421-9904View further author information
, M.D.https://orcid.org/0000-0001-8421-9904View further author information